Check out this awesome piece in UVAToday, highlighting Dr. Alban Gaultier (Dept of Neuroscience, Director, NGP) and his former BIMS student Dorian A. Rosen.

Their finding that fluvoxamine may stop the deadly inflammation known as sepsis inspired clinical trials at Washington University to investigate potential reduction of cytokines in cases of COVID-19.

Here is where you can find Drs Gaultier and Rosen's original publication in Science Translational Medicine.